Alaunos Therapeutics, Inc. Common Stock, Value, Issued
Alaunos Therapeutics, Inc. (TCRT) had Common Stock, Value, Issued of $2.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-14
- 2026-06-30: Common Stock, Value, Issued $2.00K.
- 2026-03-31: Common Stock, Value, Issued $2.00K.
- 2025-12-31: Common Stock, Value, Issued $2.00K.
- 2025-09-30: Common Stock, Value, Issued $2.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $2.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $16.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $2.00K 10-K · filed 2025-03-31 | $16.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | $241.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $241.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $241.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $16.00K 10-K · filed 2024-04-01 | $240.00K 10-K · filed 2023-03-07 |
| 2022-09-30 | $216.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $216.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $216.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $216.00K 10-K · filed 2023-03-07 | |
| 2021-09-30 | $216.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $216.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $215.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $215.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $214.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $214.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $214.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $182.00K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $181.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $162.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $162.00K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $161.00K 10-K · filed 2020-03-02 | |
| 2018-09-30 | $142.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $142.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $142.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $143.00K 10-K · filed 2019-03-05 | |
| 2017-09-30 | $142.00K 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $142.00K 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $132.00K 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $132.00K 10-K · filed 2018-03-01 | |
| 2016-09-30 | $132.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $132.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $132.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $132.00K 10-K · filed 2017-02-16 | |
| 2015-09-30 | $131.00K 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $131.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $128.00K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $104.00K 10-K · filed 2016-02-24 | |
| 2014-09-30 | $103.00K 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $101.00K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $101.00K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $100.00K 10-K · filed 2015-02-26 | |
| 2013-09-30 | $84.00K 10-Q · filed 2013-10-22 | |
| 2013-06-30 | $84.00K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $84.00K 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $83.00K 10-K · filed 2014-03-03 | |
| 2012-09-30 | $80.00K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $80.00K 10-Q/A · filed 2012-08-28 | |
| 2012-03-31 | $80.00K 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $69.00K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $68.00K 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $68.00K 10-Q/A · filed 2011-08-09 | |
| 2010-12-31 | $48.00K 10-K · filed 2012-02-29 | |
| 2010-09-30 | $49.00K 10-Q · filed 2011-08-01 | |
| 2009-12-31 | $42.00K 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |